Prescription Drug Information: Albuterol Sulfate

ALBUTEROL SULFATE- albuterol sulfate solution
The Ritedose Corporation

NDC 60687- 395 -83

Albuterol Sulfate Inhalation Solution, 0.083%*

2.5 mg/3 mL*

*Potency expressed as albuterol, equivalent to 3 mg albuterol sulfate.

30 x 3 mL Sterile Unit-Dose Vials,

each in a foil pouch

Rx Only

FOR ORAL INHALATION ONLY

Principal Display Panel — AHP Albuterol Sulfate 30 ct Carton

NDC 60687- 395 -83

Albuterol Sulfate Inhalation Solution, 0.083%*

2.5 mg/3 mL*

*Potency expressed as albuterol, equivalent to 3 mg albuterol sulfate.

30 x 3 mL Sterile Unit-Dose Vials,

each in a foil pouch

Rx Only

FOR ORAL INHALATION ONLY

AHP Albuterol Sulfate 30 ct Carton
(click image for full-size original)
ALBUTEROL SULFATE
albuterol sulfate solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65302-045
Route of Administration RESPIRATORY (INHALATION) DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALBUTEROL SULFATE (ALBUTEROL) ALBUTEROL 2.5 mg in 3 mL
Inactive Ingredients
Ingredient Name Strength
SULFURIC ACID
WATER
SODIUM CHLORIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65302-045-01 30 POUCH in 1 CARTON contains a POUCH
1 1 AMPULE in 1 POUCH This package is contained within the CARTON (65302-045-01) and contains a AMPULE
1 3 mL in 1 AMPULE This package is contained within a POUCH and a CARTON (65302-045-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077839 12/26/2018
Labeler — The Ritedose Corporation (837769546)
Establishment
Name Address ID/FEI Operations
The Ritedose Corporation 837769546 analysis (65302-045), manufacture (65302-045), pack (65302-045), label (65302-045)

Revised: 12/2019 The Ritedose Corporation

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.